Annandale Capital’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Hold |
|
|||||
|
2025
Q1 | $836K | Hold |
|
|||||
|
2024
Q4 | $805K | Hold |
|
|||||
|
2024
Q3 | $960K | Hold |
|
|||||
|
2024
Q2 | $1.27M | Sell |
|
|||||
|
2024
Q1 | $1.22M | Sell |
|
|||||
|
2023
Q4 | $1.23M | Hold |
|
|||||
|
2023
Q3 | $1.15M | Sell |
|
|||||
|
2023
Q2 | $873K | Hold |
|
|||||
|
2023
Q1 | $779K | Hold |
|
|||||
|
2022
Q4 | $748K | Hold |
|
|||||
|
2022
Q3 | $702K | Hold |
|
|||||
|
2022
Q2 | $691K | Hold |
|
|||||
|
2022
Q1 | $735K | Sell |
|
|||||
|
2021
Q4 | $820K | Hold |
|
|||||
|
2021
Q3 | $1.45M | Hold |
|
|||||
|
2021
Q2 | $1.32M | Hold |
|
|||||
|
2021
Q1 | $1.68M | Hold |
|
|||||
|
2020
Q4 | $1.55M | Buy |
|